{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:17:18Z","timestamp":1792289838256,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T00:00:00Z","timestamp":1360886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00277-013-1692-6","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T08:26:24Z","timestamp":1360830384000},"page":"739-746","source":"Crossref","is-referenced-by-count":17,"title":["Hepatitis C in patients with \u03b2-thalassemia major. A single-centre experience"],"prefix":"10.1007","volume":"92","author":[{"given":"Christos","family":"Triantos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kourakli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kalafateli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Giannakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Koukias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Thomopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polixeni","family":"Lampropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bartzavali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Fragopanagou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Kagadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirto","family":"Christofidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsamandas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Nikolopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Karakantza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryssoula","family":"Labropoulou-Karatza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"1692_CR1","first-page":"1187","volume":"89","author":"C Borgna-Pignatti","year":"2004","unstructured":"Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187\u20131193","journal-title":"Haematologica"},{"key":"1692_CR2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0609.2011.01582.x","volume":"86","author":"V Ladis","year":"2011","unstructured":"Ladis V, Chouliaras G, Berdoukas V, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Kattamis A, Karagiorga-Lagana M (2011) Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population. Eur J Haematol 86:332\u2013338","journal-title":"Eur J Haematol"},{"key":"1692_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000171088","volume":"120","author":"K Charafeddine","year":"2008","unstructured":"Charafeddine K, Isma\u2019eel H, Charafeddine M, Inati A, Koussa S, Naja M, Taher A (2008) Survival and complications of beta-thalassemia in Lebanon: a decade's experience of centralized care. Acta Haematol 120:112\u2013116","journal-title":"Acta Haematol"},{"issue":"8653","key":"1692_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","volume":"2","author":"MG Zurlo","year":"1989","unstructured":"Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S (1989) Survival and causes of death in thalassaemia major. Lancet 2(8653):27\u201330","journal-title":"Lancet"},{"issue":"8","key":"1692_CR5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.13500","volume":"93","author":"E Angelucci","year":"2008","unstructured":"Angelucci E, Pilo F (2008) Treatment of hepatitis C in patients with thalassemia. Haematologica 93(8):1121\u20131123","journal-title":"Haematologica"},{"key":"1692_CR6","first-page":"1179","volume":"89","author":"D Prati","year":"2004","unstructured":"Prati D, Maggioni M, Milani S, Cerino M, Cianciulli P, Coggi G, Forni GL, Magnano C, Meo A, Gramignoli R, Rebulla P, Fiorelli G, Cappellini MD (2004) Cooleycare Cooperative Group. Clinical and histological characterization of liver disease in patients with transfusion-dependent \u03b2-thalassemia. A multicenter study of 117 cases. Haematologica 89:1179\u20131186","journal-title":"Haematologica"},{"key":"1692_CR7","first-page":"1136","volume":"90","author":"V Perifanis","year":"2005","unstructured":"Perifanis V, Tziomalos K, Tsatra I, Karyda S, Patsiaoura K, Athanassiou-Metaxa M (2005) Prevalence and severity of liver disease in patients with \u03b2 thalassemia major. A single-institution fifteen-year experience. Haematologica 90:1136\u20131138","journal-title":"Haematologica"},{"key":"1692_CR8","first-page":"353","volume":"79","author":"E Angelucci","year":"1994","unstructured":"Angelucci E (1994) Antibodies to hepatitis C virus in thalassemia. Haematologica 79:353\u2013355","journal-title":"Haematologica"},{"key":"1692_CR9","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1182\/blood-2009-11-248724","volume":"116","author":"V Marco Di","year":"2010","unstructured":"Di Marco V, Capra M, Angelucci E, Borgna-Pignatti C, Telfer P, Harmatz P, Kattamis A, Prossamariti L, Filosa A, Rund D, Gamberini MR, Cianciulli P, De Montalembert M, Gagliardotto F, Foster G, Grang\u00e8 JD, Cassar\u00e0 F, Iacono A, Cappellini MD, Brittenham GM, Prati D, Pietrangelo A, Crax\u00ec A, Maggio A, Italian Society for the Study of Thalassemia and Haemoglobinopathies, Italian Association for the Study of the Liver (2010) Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood 116:2875\u20132883","journal-title":"Blood"},{"key":"1692_CR10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1751-553X.2009.01155.x","volume":"32","author":"L Ragab","year":"2010","unstructured":"Ragab L, Helal S, Zaghloul N, El-Raziky M, Afifi R, Musallam KM, Taher AT (2010) Clinicovirologic analysis of hepatitis C infection in transfusion-dependent \u03b2-thalassemia major children. Int J Lab Hematol 32:184\u2013190","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"1692_CR11","first-page":"64","volume":"103","author":"A Chakravarti","year":"2005","unstructured":"Chakravarti A, Verma V, Kumaria R, Dubei AP (2005) Anti-HCV seropositivity among multiple transfused patients with beta thalassaemia. J Indian Med Assoc 103(2):64\u201366","journal-title":"J Indian Med Assoc"},{"issue":"6","key":"1692_CR12","first-page":"2207","volume":"90","author":"V Marco Di","year":"1997","unstructured":"Di Marco V, Lo IO, Almasio P, Ciaccio C, Capra M, Rizzo M, Malizia R, Maggio A, Fabiano C, Barbaria F, Crax\u00ec A (1997) Long-term efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C. Blood 90(6):2207\u20132212","journal-title":"Blood"},{"issue":"4","key":"1692_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2893.2009.01170.x","volume":"17","author":"SM Alavian","year":"2010","unstructured":"Alavian SM, Tabatabaei SV (2010) Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis. J Viral Hepat 17(4):236\u2013244","journal-title":"J Viral Hepat"},{"issue":"8","key":"1692_CR14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3324\/haematol.12352","volume":"93","author":"P Harmatz","year":"2008","unstructured":"Harmatz P, Jonas MM, Kwiatkowski JL, Wright EC, Fischer R, Vichinsky E, Giardina PJ, Neufeld EJ, Porter J, Olivieri N, Thalassemia Clinical Research Network (2008) Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica 93(8):1247\u20131251","journal-title":"Haematologica"},{"issue":"7","key":"1692_CR15","first-page":"65","volume":"4","author":"S Mirmomen","year":"2004","unstructured":"Mirmomen S, Daryani NE, Malekzadeh R et al (2004) The efficacy and safety of peginterferon alpha-2a (PEGASYS) in the treatment of chronic hepatitis C infected subjects with transfusion dependent thalassemia. Hepat Mon 4(7):65\u201370","journal-title":"Hepat Mon"},{"key":"1692_CR16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1196\/annals.1345.067","volume":"1054","author":"V Ladis","year":"2005","unstructured":"Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C (2005) Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci 1054:445\u2013450","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"1692_CR17","first-page":"1157","volume":"89","author":"A Cao","year":"2004","unstructured":"Cao A (2004) Quality of life and survival of patients with beta-thalassemia major. Haematologica 89(10):1157\u20131159","journal-title":"Haematologica"},{"issue":"3","key":"1692_CR18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2141.2002.03491.x","volume":"117","author":"CK Li","year":"2002","unstructured":"Li CK, Chan PK, Ling SC, Ha SY (2002) Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol 117(3):755\u2013758","journal-title":"Br J Haematol"},{"issue":"6","key":"1692_CR19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696\u2013699","journal-title":"J Hepatol"},{"issue":"3","key":"1692_CR20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0016-5085(81)90019-6","volume":"80","author":"P Brissot","year":"1981","unstructured":"Brissot P, Bourel M, Herry D, Verger JP, Messner M, Beaumont C, Regnouard F, Ferrand B, Simon M (1981) Assessment of liver iron content in 271 patients: a re-evaluation of direct and indirect methods. Gastroenterology 80(3):557\u2013565","journal-title":"Gastroenterology"},{"issue":"4","key":"1692_CR21","first-page":"195","volume":"41","author":"MB Agarwal","year":"1993","unstructured":"Agarwal MB, Malkan GH, Bhave AA, Vishwanathan C, Billa V, Dube SR, Bajan K, Rajadhyaksha GC, Shah SH (1993) Antibody to hepatitis-C virus in multi-transfused thalassaemics\u2014Indian experience. J Assoc Phys India 41(4):195\u2013197","journal-title":"J Assoc Phys India"},{"issue":"11","key":"1692_CR22","first-page":"1611","volume":"29","author":"M Ameli","year":"2008","unstructured":"Ameli M, Besharati S, Nemati K, Zamani F (2008) Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in northern Iran. Saudi Med J 29(11):1611\u20131615","journal-title":"Saudi Med J"},{"issue":"8","key":"1692_CR23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF01957724","volume":"151","author":"M Resti","year":"1992","unstructured":"Resti M, Azzari C, Rossi ME, Vullo C, Zammarchi E, Vierucci A (1992) Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis. Eur J Pediatr 151(8):573\u2013576","journal-title":"Eur J Pediatr"},{"issue":"4","key":"1692_CR24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00005176-199305000-00020","volume":"16","author":"M Lai","year":"1993","unstructured":"Lai M, De Virgilis S, Argiolu F, Farci P, Mazzoleni AP, Lisci V, Rapicetta M, Clemente MG, Nurchis P, Arnone M et al (1993) Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay. J Pediatr Gastroenterol Nutr 16(4):458\u2013464","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"1692_CR25","first-page":"555","volume":"23","author":"M Chiaramonte","year":"1991","unstructured":"Chiaramonte M, Stroffolini T, Caporaso N, Coppola R, Crax\u00ec A, Gaeta GB, Sagnelli E, Zanetti AR (1991) Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). Ital J Gastroenterol 23(9):555\u2013558","journal-title":"Ital J Gastroenterol"},{"key":"1692_CR26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1749-6632.1990.tb24291.x","volume":"612","author":"A Maggio","year":"1990","unstructured":"Maggio A, Di Marzo R, Giambona A, Renda M, Acuto S, Lo Gioco P, D'Alcamo E, Di Trapani F, Marino M, Abate I et al (1990) Beta-thalassemia mutations in Sicily. Ann N Y Acad Sci 612:67\u201373","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1692_CR27","first-page":"369","volume":"14","author":"B Erer","year":"1994","unstructured":"Erer B, Angelucci E, Lucarelli G, Giardini C, Baronciani D, Galimberti M, Polchi P, Amadei G, Battistini L, Paolucci S et al (1994) Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 14(3):369\u2013372","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"1692_CR28","first-page":"982","volume":"97","author":"W Sievert","year":"2002","unstructured":"Sievert W, Pianko S, Warner S, Bowden S, Simpson I, Bowden D, Locarnini S (2002) Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major. Am J Gastroenterol 97(4):982\u2013987","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1692_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood.V100.1.17","volume":"100","author":"E Angelucci","year":"2002","unstructured":"Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J, Ripalti M, Sodani P, Tomassoni S, Visani G, Lucarelli G (2002) Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 100(1):17\u201321","journal-title":"Blood"},{"issue":"3","key":"1692_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0953-6205(00)00081-9","volume":"11","author":"C Labropoulou-Karatza","year":"2000","unstructured":"Labropoulou-Karatza C, Goritsas C, Fragopanagou H, Matsouka P, Spiliopoulou II, Barbatis C (2000) Adult beta-thalassemic patients with chronic hepatitis C: long-term efficacy of alpha-IFN treatment. Eur J Intern Med 11(3):161\u2013164","journal-title":"Eur J Intern Med"},{"issue":"6","key":"1692_CR31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1179\/joc.2005.17.6.651","volume":"17","author":"R Artan","year":"2005","unstructured":"Artan R, Akcam M, Yilmaz A, Kocacik D (2005) Interferon alpha monotherapy for chronic hepatitis C viral infection in thalassemics and hemodialysis patients. J Chemother 17(6):651\u2013655","journal-title":"J Chemother"},{"issue":"10","key":"1692_CR32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s100960050383","volume":"18","author":"I Spiliopoulou","year":"1999","unstructured":"Spiliopoulou I, Repanti M, Katinakis S, Karana-Ginopoulou A, Papanastasiou DA (1999) Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C. Eur J Clin Microbiol Infect Dis 18(10):709\u2013715","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"1692_CR33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0168-8278(91)90814-R","volume":"13","author":"F Tin\u00e8","year":"1991","unstructured":"Tin\u00e8 F, Magrin S, Crax\u00ec A, Pagliaro L (1991) Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol 13(2):192\u2013199","journal-title":"J Hepatol"},{"issue":"4","key":"1692_CR34","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1046\/j.1365-2141.1997.2953112.x","volume":"98","author":"PT Telfer","year":"1997","unstructured":"Telfer PT, Garson JA, Whitby K, Grant PR, Yardumian A, Hoffbrand AV, Wonke B (1997) Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. Br J Haematol 98(4):850\u2013855","journal-title":"Br J Haematol"},{"issue":"4","key":"1692_CR35","doi-asserted-by":"crossref","first-page":"785","DOI":"10.26719\/2009.15.4.785","volume":"15","author":"MJ Saffar","year":"2009","unstructured":"Saffar MJ, Saffar H, Khlilian AR, Naqshvar F (2009) Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major. East Mediterr Health J 15(4):785\u2013791","journal-title":"East Mediterr Health J"},{"issue":"4","key":"1692_CR36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2005.05645.x","volume":"130","author":"A Inati","year":"2005","unstructured":"Inati A, Taher A, Ghorra S, Koussa S, Taha M, Aoun E, Sharara AI (2005) Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. Br J Haematol 130(4):644\u2013646","journal-title":"Br J Haematol"},{"key":"1692_CR37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(94)70138-5","volume":"125","author":"MG Clemente","year":"1994","unstructured":"Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, Faa G, Diana G, Dess\u00ec C et al (1994) Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 125:123\u2013128","journal-title":"J Pediatr"},{"issue":"6","key":"1692_CR38","first-page":"502","volume":"77","author":"V Marco Di","year":"1992","unstructured":"Di Marco V, Lo IO, Capra M, Grutta S, Ciaccio C, Gerardi C, Maggio A, Renda D, Almasio P, Pisa R et al (1992) Alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia. Haematologica 77(6):502\u2013506","journal-title":"Haematologica"},{"issue":"3","key":"1692_CR39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2141.1993.tb04676.x","volume":"83","author":"SM Donohue","year":"1993","unstructured":"Donohue SM, Wonke B, Hoffbrand AV, Reittie J, Ganeshaguru K, Scheuer PJ, Brown D, Dusheiko G (1993) Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major. Br J Haematol 83(3):491\u2013497","journal-title":"Br J Haematol"},{"issue":"1","key":"1692_CR40","first-page":"129","volume":"90","author":"V Syriopoulou","year":"2005","unstructured":"Syriopoulou V, Daikos GL, Kostaridou SL, Manolaki N, Nakopoulou L, Kattamis A, Kattamis C (2005) Sustained response to interferon alpha-2a in thalassemic patients with chronic hepatitis C. A prospective 8-year follow-up study. Haematologica 90(1):129\u2013131","journal-title":"Haematologica"},{"issue":"7","key":"1692_CR41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/MEG.0b013e3283097699","volume":"21","author":"D Ancel","year":"2009","unstructured":"Ancel D, Amiot X, Chaslin-Ferbus D, Hagege I, Garioud A, Girot R, Pol S, Grange JD (2009) Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin. Eur J Gastroenterol Hepatol 21(7):726\u2013729","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"1692_CR42","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3324\/haematol.12554","volume":"93","author":"V Marco Di","year":"2008","unstructured":"Di Marco V, Capra M, Gagliardotto F, Borsellino Z, Cabibi D, Barbaria F, Ferraro D, Cuccia L, Ruffo GB, Bronte F, Di Stefano R, Almasio PL, Crax\u00ec A (2008) Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. Haematologica 93(8):1243\u20131246","journal-title":"Haematologica"},{"issue":"4","key":"1692_CR43","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/j.gastro.2011.06.065","volume":"141","author":"Y Deugnier","year":"2011","unstructured":"Deugnier Y, Turlin B, Ropert M, Cappellini MD, Porter JB, Giannone V, Zhang Y, Griffel L, Brissot P (2011) Improvement in liver pathology of patients with \u03b2-thalassemia treated with deferasirox for at least 3 years. Gastroenterology 141(4):1202\u20131211","journal-title":"Gastroenterology"},{"key":"1692_CR44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0098-2997(00)00004-2","volume":"21","author":"G Poli","year":"2000","unstructured":"Poli G (2000) Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21:49\u201398","journal-title":"Mol Aspects Med"},{"issue":"1","key":"1692_CR45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03630260500455565","volume":"30","author":"A Mancuso","year":"2006","unstructured":"Mancuso A, Sciarrino E, Renda MC, Maggio A (2006) A prospective study of hepatocellular carcinoma incidence in thalassemia. Hemoglobin 30(1):119\u2013124","journal-title":"Hemoglobin"},{"issue":"1","key":"1692_CR46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2003.04732.x","volume":"124","author":"C Borgna-Pignatti","year":"2004","unstructured":"Borgna-Pignatti C, Vergine C, Lombardo T, Cappellini MD, Cianciulli P, Maggio A, Renda D, Lai ME, Mandas A, Forni G, Piga A, Bisconte MG (2004) Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 124(1):114\u2013117","journal-title":"Br J Haematol"},{"key":"1692_CR47","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825\u2013832","journal-title":"Lancet"},{"key":"1692_CR48","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1056\/NEJM199909163411202","volume":"341","author":"M Vogt","year":"1999","unstructured":"Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A, Wiebecke B, Langer B, Meisner H, Hess J (1999) Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341:866\u2013870","journal-title":"N Engl J Med"},{"issue":"3","key":"1692_CR49","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2011.03.006","volume":"55","author":"CM Lange","year":"2011","unstructured":"Lange CM, Zeusem S (2011) IL28B single nucleotide polymorphisms in the treatment of hepatitis C. J Hepatol 55(3):692\u2013701","journal-title":"J Hepatol"},{"issue":"3","key":"1692_CR50","doi-asserted-by":"crossref","first-page":"e18322","DOI":"10.1371\/journal.pone.0018322","volume":"6","author":"CY Lin","year":"2011","unstructured":"Lin CY, Chen JY, Lin TN et al (2011) IL28B SNP rs 12979860 is a clinical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype 1 infection. PLoS One 6(3):e18322","journal-title":"PLoS One"},{"key":"1692_CR51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399\u2013401","journal-title":"Nature"},{"issue":"5","key":"1692_CR52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3324\/haematol.2011.050351","volume":"97","author":"V Marco Di","year":"2012","unstructured":"Di Marco V, Bronte F, Calvaruso V, Capra M, Capra M, Borsellino Z, Maggio A, Renda MC, Pitrolo L, Lo Pinto MC, Rizzo M, Fiorenza F, Gerardi C, Grimaudo S, Di Cristina A, Levrero M, Crax\u00ec A (2012) IL28B polymorphisms influence stage of the liver fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Haematologica 97(5):679\u2013686","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1692-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1692-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1692-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T18:46:58Z","timestamp":1562698018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1692-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1692-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,15]]}}}